Skip to content

Probiotic Versus Placebo as Adjuvant for Bacterial Vaginosis Treatment During Pregnancy

Randomised Control Trial of Probiotics Versus Placebo as Adjuvant to Oral Clindamycin Treatment for Bacterial Vaginosis During Pregnancy

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01558388
Enrollment
100
Registered
2012-03-20
Start date
2009-09-30
Completion date
2012-12-31
Last updated
2012-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bacterial Vaginosis

Brief summary

Bacterial vaginosis is a common vaginal condition involving a reduction in the amount of Lactobacilli, the normal bacteria colonizing the vagina, and an overgrowth of pathogenic bacteria. The presence of bacterial vaginosis in pregnancy is associated with an increased risk of preterm delivery. After a course of antibiotic treatment, recurrence of bacterial vaginosis has been reported in 10-70% of cases. This study aims to verify if administration of vaginal Lactobacilli may reduce the occurrence rate after antibiotic treatment of bacterial vaginosis during pregnancy.

Interventions

Lactobacillus acidophilus 500 million colony-forming units/tablets. One vaginal tablet daily for 10 days.

DRUGPlacebo

One vaginal tablet daily for 10 days.

Sponsors

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
CollaboratorOTHER
Università degli Studi di Brescia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* singleton pregnancy * gestational age 12-32 weeks * diagnosis of bacterial vaginosis * treatment of bacterial vaginosis with oral clindamycin 300 mg, twice-daily for 7 days

Exclusion criteria

* multiple pregnancy * allergy to clindamycin

Design outcomes

Primary

MeasureTime frame
Vaginal lactobacillus recolonization3-5 weeks
Recurrence rate of bacterial vaginosis3-5 weeks

Secondary

MeasureTime frame
Preterm delivery <37 weekswithin 43 weeks of gestation

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026